146 related articles for article (PubMed ID: 2927643)
1. Synaptic loss in Alzheimer's disease and other dementias.
Hamos JE; DeGennaro LJ; Drachman DA
Neurology; 1989 Mar; 39(3):355-61. PubMed ID: 2927643
[TBL] [Abstract][Full Text] [Related]
2. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies.
Lippa CF
Am J Alzheimers Dis Other Demen; 2004; 19(6):341-4. PubMed ID: 15633942
[TBL] [Abstract][Full Text] [Related]
3. The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease.
Haytural H; Mermelekas G; Emre C; Nigam SM; Carroll SL; Winblad B; Bogdanovic N; Barthet G; Granholm AC; Orre LM; Tjernberg LO; Frykman S
Mol Cell Proteomics; 2020 Jan; 19(1):128-141. PubMed ID: 31699905
[TBL] [Abstract][Full Text] [Related]
4. Staging of Alzheimer's disease-related neurofibrillary changes.
Braak H; Braak E
Neurobiol Aging; 1995; 16(3):271-8; discussion 278-84. PubMed ID: 7566337
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of local mRNA dynamics and translation following long-term potentiation and depression.
Donlin-Asp PG; Polisseni C; Klimek R; Heckel A; Schuman EM
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33771924
[TBL] [Abstract][Full Text] [Related]
6. Decreased neuronal synaptosome associated protein 29 contributes to poststroke cognitive impairment by disrupting presynaptic maintenance.
Yan W; Fan J; Zhang X; Song H; Wan R; Wang W; Yin Y
Theranostics; 2021; 11(10):4616-4636. PubMed ID: 33754017
[No Abstract] [Full Text] [Related]
7. Structural correlates of cognition in dementia: quantification and assessment of synapse change.
DeKosky ST; Scheff SW; Styren SD
Neurodegeneration; 1996 Dec; 5(4):417-21. PubMed ID: 9117556
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Long JM; Holtzman DM
Cell; 2019 Oct; 179(2):312-339. PubMed ID: 31564456
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice.
Bai N; Li N; Cheng R; Guan Y; Zhao X; Song Z; Xu H; Yi F; Jiang B; Li X; Wu X; Jiang C; Zhou T; Guo Q; Guo W; Feng Y; Wang Z; Ma M; Yu Y; Wang Z; Zhang S; Wang C; Zhao W; Liu S; Song X; Liu H; Cao L
Cell Rep; 2022 Jul; 40(2):111062. PubMed ID: 35830807
[TBL] [Abstract][Full Text] [Related]
10. The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis.
Yi F; Zhang Y; Wang Z; Wang Z; Li Z; Zhou T; Xu H; Liu J; Jiang B; Li X; Wang L; Bai N; Guo Q; Guan Y; Feng Y; Mao Z; Fan G; Zhang S; Wang C; Cao L; O'Rourke BP; Wang Y; Wu Y; Wu B; You S; Zhang N; Guan J; Song X; Sun Y; Wei S; Cao L
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627431
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases.
Manjula R; Anuja K; Alcain FJ
Front Pharmacol; 2020; 11():585821. PubMed ID: 33597872
[TBL] [Abstract][Full Text] [Related]
12. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model.
Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL
Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
Zhang T; Chen D; Lee TH
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
[TBL] [Abstract][Full Text] [Related]
14. APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model.
Deyts C; Clutter M; Pierce N; Chakrabarty P; Ladd TB; Goddi A; Rosario AM; Cruz P; Vetrivel K; Wagner SL; Thinakaran G; Golde TE; Parent AT
Cell Rep; 2019 Apr; 27(5):1345-1355.e6. PubMed ID: 31042463
[TBL] [Abstract][Full Text] [Related]
15. The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation.
Tackenberg C; Nitsch RM
Mol Brain; 2019 Mar; 12(1):27. PubMed ID: 30922360
[TBL] [Abstract][Full Text] [Related]
16. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation in Neurodegenerative Diseases.
Berson A; Nativio R; Berger SL; Bonini NM
Trends Neurosci; 2018 Sep; 41(9):587-598. PubMed ID: 29885742
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy.
Min SW; Sohn PD; Li Y; Devidze N; Johnson JR; Krogan NJ; Masliah E; Mok SA; Gestwicki JE; Gan L
J Neurosci; 2018 Apr; 38(15):3680-3688. PubMed ID: 29540553
[TBL] [Abstract][Full Text] [Related]
19. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease.
Selkoe DJ
Trends Cell Biol; 1998 Nov; 8(11):447-53. PubMed ID: 9854312
[TBL] [Abstract][Full Text] [Related]
20. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.
Meziane H; Dodart JC; Mathis C; Little S; Clemens J; Paul SM; Ungerer A
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12683-8. PubMed ID: 9770546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
